Does FOSTAMATINIB Cause Agranulocytosis? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Agranulocytosis have been filed in association with FOSTAMATINIB (TAVALISSE). This represents 0.1% of all adverse event reports for FOSTAMATINIB.
6
Reports of Agranulocytosis with FOSTAMATINIB
0.1%
of all FOSTAMATINIB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Agranulocytosis From FOSTAMATINIB?
Of the 6 reports, 5 (83.3%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSTAMATINIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does FOSTAMATINIB Cause?
Diarrhoea (904)
Platelet count decreased (804)
Product dose omission issue (711)
Off label use (680)
Hospitalisation (403)
Platelet count (375)
Drug ineffective (340)
Fatigue (332)
Blood pressure increased (314)
Death (307)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which FOSTAMATINIB Alternatives Have Lower Agranulocytosis Risk?
FOSTAMATINIB vs FOSTEMSAVIR TROMETHAMINE
FOSTAMATINIB vs FOTEMUSTINE
FOSTAMATINIB vs FRAMYCETIN
FOSTAMATINIB vs FREMANEZUMAB
FOSTAMATINIB vs FREMANEZUMAB-VFRM